Mayo Clinic Researchers ID Potential Gene Marker for Treating Pancreatic Cancer

by admin | Dec 31, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Joe Dangor – Mayo Clinic ROCHESTER, Minn. — Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC). The researcher’s findings are...

CRISPR cancer trial success paves the way for personalized treatments

by admin | Dec 30, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Heidi Ledford – Nature ‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours. A small clinical trial has shown that researchers can use CRISPR gene editing to alter immune cells so that they will recognize mutated...

Addressing the challenges of chimeric antigen receptor-T cell therapy

by admin | Dec 29, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Susan Murphy – Mayo Clinic Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) — a type of immunotherapy that reprograms a patient’s T cells to recognize and destroy cancer cells — has revolutionized the treatment of blood cancers. While the...

Monoclonal antibodies preserve stem cells in mouse brains, bring promise for future studies

by admin | Dec 29, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Noah Fromson – University of Michigan Health Image caption: Human neural stem cell transplants (green) survive and migrate throughout the mouse brain (blue) when given a novel monoclonal antibody treatment. Michigan Medicine Using antibodies instead of...

Cell and Gene Therapy: Current Challenges and the Benefits of Automation

by admin | Dec 28, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Anna MacDonald and Sarah Whelan – Technology Networks Cell and gene therapy is a field of personalized medicine, driving the innovation of medicine and revolutionizing the way we treat disease. Gene therapies use DNA or other genetic material to edit a...

Trial of Stem Cell-derived Therapy for Parkinson’s to Open in Sweden

by admin | Dec 27, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Margarida Maia, PhD – Parkinson’s News Today A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s disease has been approved by the Swedish Medical Products Agency. The therapy, called STEM-PD,...